Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19191
Title: Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/administration &,dosage/*therapeutic use,Breast Neoplasms/*drug therapy/surgery,Cyclophosphamide/administration & dosage,Disease-Free Survival,Dose-Response Relationship, Drug,Epirubicin/administration & dosage,Female,Fluorouracil/administration & dosage,Humans,Methotrexate/administration & dosage,Middle Aged,Paclitaxel/administration & dosage,Risk Factors,Survival Rate,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19191
ISSN: 0923-7534
Link: http://www.ncbi.nlm.nih.gov/pubmed/16148021
http://annonc.oxfordjournals.org/content/16/11/1762.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Fountzilas-2005-Postoperative dose-d.pdf166.69 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons